Medicine
Anavip 12 mg/mL powder for injection
Anavip 12 mg/mL powder for injection is a prescription medicine containing Pit viper (crotalinae) immune globulin antivenin (equine) for intravenous use, marketed by Rare Disease Therapeutics, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
DO NOT FREEZE. Store at room temperature (up to 25 ºC (77 ºF)). Brief…
Key facts
- Active ingredient (INN)
- Pit viper (crotalinae) immune globulin antivenin (equine)
- Brand
- Anavip
- Strength
- 12 mg/mL
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 1 vial
- Marketing authorisation holder
- Rare Disease Therapeutics
- Manufacturer
- Rare Disease Therapeutics
- Origin register
- US FDA, United States
- Storage
- DO NOT FREEZE. Store at room temperature (up to 25 ºC (77 ºF)). Brief temperature excursions are permitted up to 40 ºC (104ºF).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3002.12Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 6 May 2015
- Identifiers
- RxCUI 2101275, 2101280DailyMed set ID a16596a5-e87e-40c2-8e34-cea5839849c3NDC 66621-0790Application BLA125488
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial in 1 carton / 10 mL in 1 vial | 66621-0790-2 | Rare Disease Therapeutics | 6 May 2015 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Pit viper (crotalinae) immune globulin antivenin (equine) is a prescription medicine indicated for the management of adult and pediatric patients with North American Pit Viper envenomation. MedsAcross supplies Pit viper (crotalinae) immune globulin antivenin (equine) for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Pit viper (crotalinae) immune globulin antivenin (equine)For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ANAVIP prescribing information (Rare Disease Therapeutics) · U.S. National Library of Medicine, DailyMed
Need Anavip 12 mg/mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.